HemOnc Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents
Cover Story

Making lifestyle changes ‘part of the cancer treatment conversation’

‘Precision nutrition’ may be on the horizon, but large-scale, definitive trials lacking

Lindsay L. Peterson, MD, MSCR

American Society for Radiation Oncology announces president-elect, new board members

Editorial

The unspoken truth about financial toxicity

John Sweetenham, MD

Advanced Practice

APPs can serve as ‘advocate, coordinator’ for patients with chronic GVHD

Linda M. Perry, MS, PA-C

Molecular Oncology

Risk, phenotypes, therapeutics and resistance

Wafik S. El-Deiry, MD, PhD, FACP

Feature

Study to evaluate breast cancer screening approaches amid mammography guidelines debate

Expense reimbursement model aims to ‘level playing field’ for clinical trial participation

Meeting News

Factors may help predict which patients with HER2-positive breast cancer can forgo surgery

Anticoagulants may reduce VTE risk in children

In the Journals

FDA-approved cancer drugs take more than 6 years to reach children

Direct oral anticoagulants safe, effective in patients with VTE and thrombophilia

Alpelisib plus fulvestrant extends PFS in PIK3CA-mutated advanced breast cancer

Colorectal cancer subtypes could help predict best initial treatment option

Gene expression patterns identify high-risk chronic lymphocytic leukemia

Osimertinib shows 'consistent improvement' in post-progression endpoints for non-small cell lung cancer

Persistent HPV DNA may predict progression of certain head and neck cancers

FDA News

Pembrolizumab approved for two solid tumor indications

FDA approves Zirabev, biosimilar to Avastin

In the Journals

Leukemia Research Foundation awards grants to 12 investigators